Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Program in Molecular MedicineDocument Type
Journal ArticlePublication Date
2007-08-01Keywords
BiochemistryCell Biology
Cellular and Molecular Physiology
Immunology of Infectious Disease
Molecular Biology
Metadata
Show full item recordAbstract
Streptococcus pneumoniae (S. pneumoniae) causes high early mortality in pneumococcal pneumonia, which is characterized by acute lung injury (ALI). The molecular mechanisms underlying ALI and the high early mortality remain unknown. Despite recent studies that identify deubiquitinating enzyme cylindromatosis (CYLD) as a key regulator for T cell development, tumor cell proliferation, and NF-kappaB transcription factor signaling, its role in regulating bacteria-induced lethality, however, is unknown. Here, we showed that CYLD deficiency protected mice from S. pneumoniae pneumolysin (PLY)-induced ALI and lethality. CYLD was highly induced by PLY, and it inhibited MKK3-p38 kinase-dependent expression of plasminogen activator inhibitor-1 (PAI-1) in lung, thereby potentiating ALI and mortality. Thus, CYLD is detrimental for host survival, thereby indicating a mechanism underlying the high early mortality of pneumococcal pneumonia.Source
Immunity. 2007 Aug;27(2):349-60. Link to article on publisher's siteDOI
10.1016/j.immuni.2007.07.011Permanent Link to this Item
http://hdl.handle.net/20.500.14038/28334PubMed ID
17723219Notes
Full author list omitted for brevity. For full list of authors see article.
Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.immuni.2007.07.011